United States:
Judge Robinson Issues Markman Opinion In Infringement Action Construing Six Disputed Terms In Patents-in-Suit
24 October 2015
Fox Rothschild LLP
To print this article, all you need is to be registered or login on Mondaq.com.
By Memorandum Opinion entered by The Honorable Sue L. Robinson
in Amgen Inc. v. Sanofi, et al., Civil Action No.
14-317-SLR (D.Del., October 20, 2015), the Court rendered its
Markman Opinion construing six (6) disputed terms in U.S.
Patent Nos. 8,829,165("the '165 patent"), 8,859,741
("the '741 patent"), and 8,871,914 ("the
'914 patent").
A copy of the Memorandum Opinion is attached.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
"Patent Marking Regarding Software Medical Devices"
Marshall, Gerstein & Borun LLP
The IPO Law Journal recently published a paper titled "Patent Marking Regarding Software Medical Devices." The paper discusses an overview of patent marking-related case law...